BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 962 filers reported holding BAXTER INTL INC in Q3 2014. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $220,784 | -18.5% | 4,846 | -27.5% | 0.02% | -20.7% |
| Q1 2023 | $271,022 | -30.6% | 6,682 | -12.7% | 0.03% | -34.1% |
| Q4 2022 | $390,328 | -9.0% | 7,658 | -3.8% | 0.04% | -18.5% |
| Q3 2022 | $429,000 | -22.1% | 7,958 | -7.3% | 0.05% | -20.6% |
| Q2 2022 | $551,000 | -17.3% | 8,583 | 0.0% | 0.07% | -11.7% |
| Q1 2022 | $666,000 | -17.5% | 8,583 | -8.7% | 0.08% | -25.2% |
| Q4 2021 | $807,000 | +3.1% | 9,397 | -3.4% | 0.10% | -9.6% |
| Q3 2021 | $783,000 | 0.0% | 9,732 | 0.0% | 0.11% | -7.3% |
| Q2 2021 | $783,000 | -9.3% | 9,732 | -4.9% | 0.12% | -16.3% |
| Q1 2021 | $863,000 | +3.0% | 10,232 | -2.0% | 0.15% | -5.8% |
| Q4 2020 | $838,000 | -0.2% | 10,443 | 0.0% | 0.16% | -13.3% |
| Q3 2020 | $840,000 | -8.3% | 10,443 | -1.9% | 0.18% | -17.8% |
| Q2 2020 | $916,000 | +1.4% | 10,643 | -4.3% | 0.22% | -12.0% |
| Q1 2020 | $903,000 | -5.0% | 11,118 | -2.2% | 0.25% | +15.8% |
| Q4 2019 | $951,000 | -4.3% | 11,368 | 0.0% | 0.22% | -11.5% |
| Q3 2019 | $994,000 | +5.9% | 11,368 | -0.9% | 0.24% | +4.3% |
| Q2 2019 | $939,000 | 0.0% | 11,468 | -0.6% | 0.23% | -4.5% |
| Q1 2019 | $939,000 | +22.7% | 11,543 | -0.6% | 0.24% | +13.5% |
| Q4 2018 | $765,000 | -13.6% | 11,618 | +1.2% | 0.22% | -11.2% |
| Q3 2018 | $885,000 | -0.7% | 11,483 | -4.8% | 0.24% | -1.6% |
| Q2 2018 | $891,000 | +14.1% | 12,068 | +0.5% | 0.25% | +13.9% |
| Q1 2018 | $781,000 | -14.4% | 12,008 | -14.9% | 0.22% | -8.1% |
| Q4 2017 | $912,000 | -2.4% | 14,103 | -5.2% | 0.24% | -7.8% |
| Q3 2017 | $934,000 | -7.8% | 14,878 | -11.1% | 0.26% | -10.8% |
| Q2 2017 | $1,013,000 | +15.9% | 16,733 | -15.1% | 0.29% | +12.6% |
| Q1 2017 | $874,000 | 0.0% | 19,715 | 0.0% | 0.25% | +1.2% |
| Q4 2016 | $874,000 | -10.1% | 19,715 | -3.4% | 0.25% | -10.0% |
| Q3 2016 | $972,000 | -5.0% | 20,415 | -9.8% | 0.28% | -8.8% |
| Q2 2016 | $1,023,000 | +2.2% | 22,625 | -7.2% | 0.31% | +1.3% |
| Q1 2016 | $1,001,000 | -5.0% | 24,375 | -11.8% | 0.30% | -2.6% |
| Q4 2015 | $1,054,000 | +14.2% | 27,625 | -1.6% | 0.31% | +10.3% |
| Q3 2015 | $923,000 | -79.1% | 28,087 | -55.6% | 0.28% | -58.7% |
| Q2 2015 | $4,422,000 | +96.0% | 63,224 | +92.0% | 0.68% | -2.2% |
| Q1 2015 | $2,256,000 | -7.2% | 32,937 | -0.6% | 0.70% | -6.7% |
| Q4 2014 | $2,430,000 | +3.2% | 33,152 | +1.0% | 0.75% | +10.4% |
| Q3 2014 | $2,355,000 | -5.3% | 32,808 | -4.7% | 0.68% | -3.7% |
| Q2 2014 | $2,488,000 | -3.8% | 34,414 | -2.1% | 0.70% | -6.5% |
| Q1 2014 | $2,586,000 | +0.4% | 35,139 | -5.1% | 0.75% | -2.8% |
| Q4 2013 | $2,575,000 | +40.6% | 37,020 | +32.7% | 0.77% | +15.9% |
| Q3 2013 | $1,832,000 | -16.8% | 27,895 | -12.3% | 0.67% | -9.1% |
| Q2 2013 | $2,203,000 | – | 31,800 | – | 0.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |